SCHEMBL9048438

SCHEMBL9048438

COc1ccccc1N1CCN(CCN2COc3ccc(Cl)cc3C2=O)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1D P25100 3/20 0.52
ADRA1A P35348 3/20 0.52
ADRA1B P35368 3/20 0.52
DRD3 P35462 7/20 0.52
DRD2 P14416 6/20 0.52
HTR7 P34969 2/20 0.52
DRD5 P21918 1/20 0.52
KDM4E B2RXH2 2/20 0.51
ALDH1A1 P00352 2/20 0.51
HTR1A P08908 2/20 0.51
KMT2A Q03164 2/20 0.51
DRD4 P21917 2/20 0.51
MAPT P10636 1/20 0.51
MEN1 O00255 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2D6 P10635 1/20 0.51
ALOX12 P18054 1/20 0.51
HIF1A Q16665 1/20 0.51
HSD17B10 Q99714 1/20 0.51
GLA P06280 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9050903 0.89 DRD3 (0.52) ADRA1DADRA1AADRA1BDRD3DRD2
SCHEMBL9049487 0.89 DRD3 (0.58) ADRA1DADRA1AADRA1BDRD3DRD2
SCHEMBL9050089 0.88 DRD3 (0.60) ADRA1DADRA1AADRA1BDRD3DRD2
SCHEMBL9050125 0.82 DRD3 (0.64) ADRA1DADRA1AADRA1BDRD3DRD2
SCHEMBL9047811 0.82 DRD3 (0.68) ADRA1DADRA1AADRA1BDRD3DRD2
SCHEMBL9049703 0.82 DRD3 (0.69) ADRA1DADRA1AADRA1BDRD3DRD2
SCHEMBL9048565 0.74 KCNH2 (0.53) DRD2HTR7HTR1A
SCHEMBL2027865 0.74 DRD3 (0.70) ADRA1DADRA1AADRA1BDRD3DRD2
SCHEMBL9049252 0.74 ADRA1B (0.57) ADRA1DADRA1AADRA1BHTR7HTR1A
SCHEMBL28273850 0.73 HTR1A (0.77) ADRA1DADRA1AADRA1BDRD3DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0527081-B1 Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazine-4-ones, their preparation and their therapeutical use PF MEDICAMENT (FR) 1996-01-03 EP claimed
EP-0540673-B1 ACETYLENE DERIVATIVES HAVING LIPOXYGENASE INHIBITORY ACTIVITY ABBOTT LAB (US) 1996-10-16 EP disclosed
US-5559144-A LIPOXYGENASE INHIBITORS, INHIBITORS OF BIOSYNTHESIS OF LEUKOTRIENES ABBOTT LABORATORIES (US) 1996-09-24 US disclosed
US-5476873-A Inhibit biosynthesis of leukotrienes ABBOTT LABORATORIES (US) 1995-12-19 US disclosed
US-5308844-A ANTIDEPRESSANT, ANXIOLYTIC AGENT, ANALGESIC, HYPOTENSIVE AGENT PIERRE FABRE MEDICAMENT (FR) 1994-05-03 US disclosed
EP-0540673-A4 1994-04-27 EP disclosed
EP-0540673-A1 ACETYLENE DERIVATIVES HAVING LIPOXYGENASE INHIBITORY ACTIVITY. ABBOTT LAB (US) 1993-05-12 EP disclosed
WO-1992001682-A1 ACETYLENE DERIVATIVES HAVING LIPOXYGENASE INHIBITORY ACTIVITY ABBOTT LABORATORIES (US) 1992-02-06 WO disclosed